Additional serious side effects per dose were reported as follows: 4.1% of people receiving the 2.4 mg injection experienced severe nausea, vomiting, or diarrhea, versus 2% of those taking the 25 mg oral tablet
GLP-1R agonists have demonstrated interesting results in individuals with ASP (with or without OSA), while results from future RCTs and post hoc analyses from other published RCTs are anticipated (Table I)
The insurance company or policy may partially or fully cover the medication, though some plans require prior authorization for reimbursement
Meet with your provider through a convenient telehealth appointment to discuss your personalized treatment plan
As we mentioned on the Women Want Strong Men podcast, medications like Semaglutide and Tirzepatide typically make patients more in tune with their bodys signals
Finally, the simplest but most important tool: alcohol prep pads